Pharmacy Times
FEBRUARY 12, 2024
Despite the tool’s ability to predict efficacy of sertraline in patients with major depressive disorder, the investigators note that future research will seek to improve the algorithm.
STAT
FEBRUARY 12, 2024
A new study has shown that people vaccinated against Ebola who still developed the disease had a substantially lower risk of dying than people who were not vaccinated, even if they received the vaccine when they were already infected with the virus. It confirms just how major an advancement the Ebola vaccine remains; the study is the first to show that in addition to preventing infections, the vaccine can save some people who are already sick with the often fatal disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
FEBRUARY 12, 2024
As the use of artificial intelligence technology in healthcare grows, federal lawmakers are weighing how to protect patients without hindering innovation and many in Congress are pushing for strong | As the use of artificial intelligence technology in healthcare grows, federal lawmakers are weighing how to protect patients without hindering innovation and many in Congress are pushing for stronger regulation.
STAT
FEBRUARY 12, 2024
There was a time when an allegation of data mishandling, scientific misconduct, or just a technical error felt like a crisis to Barrett Rollins, an oncologist and research integrity officer at Dana-Farber Cancer Institute. Now, it’s a Tuesday. The renowned cancer treatment and research center is in the midst of a lengthy review of possible discrepancies involving around 60 papers co-authored by four of its top researchers over a period of over 15 years, including CEO Laurie Glimcher and C
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
FEBRUARY 12, 2024
The FDA approval marks the first and only FDA-approved oral therapy for this patient population, and the drug is expected to be available by the end of February.
STAT
FEBRUARY 12, 2024
A growing body of data show that South Asians are at greater risk of developing heart disease than white people, and they tend to get complications at younger ages, but it’s not been fully clear what explains this disparity. A new study suggests one potential reason is that South Asians have a decreased ability to repair blood vessels that get injured from cardiovascular problems.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 12, 2024
Super Bowl ads are a show within the show, an opportunity for brands and advertising creatives to put their work in front of more than 100 million viewers. And while the occasion is most closely associated with ads for beer, cars, and soft drinks, pharma giant Pfizer dished out millions of dollars for its own message: “Here’s to science.
Fierce Healthcare
FEBRUARY 12, 2024
Providers working in hospitals and critical access hospitals may now text patient information and patient orders among care team members without landing on the wrong side of Medicare’s Conditions o | Texting patient info has been against Medicare's Conditions of Participations for over half a decade, due to concerns of insecure texting platforms.
STAT
FEBRUARY 12, 2024
UnitedHealth Group’s Optum has bought an untold number of physician practices over the years. It either owns or is affiliated with over 90,000 providers — almost 10% of all U.S. physicians. That’s mostly happened quietly. But a new Optum purchase in Oregon is getting outsized scrutiny from state regulators — a trend experts say is actually on the rise.
Pharmacy Times
FEBRUARY 12, 2024
In addition to improved progression-free survival, patients treated with this regimen also showed improved complete response or stronger and were minimal residual disease-negative.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
FEBRUARY 12, 2024
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. The FTC doubles down on private equity and Big Physician Dominant physician groups don’t command the same attention as, say, Big Tech firms with national omnipresence like Google and Facebook.
Fierce Healthcare
FEBRUARY 12, 2024
Kaiser Permanente wrapped up its fiscal year with $329 million of operating income (0.3% operating income), net income of $4.1 billion and more than $100 billion in both operating revenues and expe | The California-based nonprofit noted cost pressures, labor challenges and membership declines but still logged a 0.3% operating income in the wake of 2022's losses.
STAT
FEBRUARY 12, 2024
Lina Khan’s Federal Trade Commission is eager to make Big Physician a lot smaller. Last September, the FTC sued private equity firm Welsh, Carson, Anderson & Stowe and U.S. Anesthesia Partners, alleging the two parties conspired to create monopolies for anesthesia services. Both Welsh Carson and USAP have tried to get the case thrown out , but the FTC recently doubled down.
pharmaphorum
FEBRUARY 12, 2024
Investing in women's health research and funding is not a charity, but a priority. Discover the importance of allocating resources and supporting initiatives that promote women's health and well-being.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
FEBRUARY 12, 2024
Gilead Sciences said Monday it will acquire CymaBay Therapeutics for $4.3 billion, adding a new treatment for a liver disease that is on track for approval later this year. The deal values CymaBay at $32.50 per share, 27% higher than the stock’s close last Friday. That’s a relatively small takeout premium, but CymaBay shares have doubled in value since last fall on growing investor confidence in the company’s lead drug and speculation that the company could be acquired.
Pharmacy Times
FEBRUARY 12, 2024
AI can pair people to foods that are best suited for their unique needs, according to a food-as-medicine entrepreneur.
Pharmaceutical Technology
FEBRUARY 12, 2024
The UK MHRA has granted approval for a variation in licence of Pfizer-BioNTech’s Comirnaty XBB.1.5 vaccine targeting Omicron variant.
Fierce Healthcare
FEBRUARY 12, 2024
The Federal Trade Commission has secured a $195 million judgement against Florida-based insurer Simple Health following allegations that it sold "sham" coverage to consumers. | The Federal Trade Commission has secured a $195 million judgement against Florida-based insurer Simple Health following allegations that it sold "sham" coverage to consumers.
Fierce Pharma
FEBRUARY 12, 2024
With a patent feud settled and its approval application back at the FDA’s desk, Sweden’s Xspray Pharma believes it's on track to launch its first commercial product late this summer. | Following a rejection in 2023, the FDA has accepted the resubmission of Xspray’s application for its leukemia candidate Dasynoc, which is seeking to dethrone Bristol Myers Squibb’s entrenched cancer blockbuster Sprycel (dasatinib).
Drug Topics
FEBRUARY 12, 2024
Your look at today’s health care headlines, including production challenges at a Aurobindo, Pfizer’s Super Bowl commercial, and Novo Nordisk’s semaglutide lawsuits.
Fierce Pharma
FEBRUARY 12, 2024
Eohilia, an oral suspension formulation of the corticosteroid budesonide, has surprisingly won over the FDA even after the drug’s developer, Takeda, had at one point abandoned the program following | Takeda's Eohilia has surprisingly won over the FDA even after the company had at one point abandoned the program following an FDA rejection. But the first FDA-approved oral eosinophilic esophagitis therapy comes with a limitation.
STAT
FEBRUARY 12, 2024
On Feb. 5, Buckingham Palace shared the news that King Charles had started treatment for cancer. Although the official statement did not include the particular type of cancer, it closed by noting that, “His Majesty has chosen to share his diagnosis to prevent speculation and in the hope it may assist public understanding for all those around the world who are affected by cancer.
Fierce Pharma
FEBRUARY 12, 2024
After a series of regulatory setbacks in Europe, PTC Therapeutics will soon find itself under a generic attack in the U.S. | After a series of regulatory setbacks in Europe, PTC Therapeutics will soon find itself under a generic attack in the U.S.
STAT
FEBRUARY 12, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Hope your team of choice was victorious in last night’s sports ball match. Today, we talk about psychedelics, obesity, and production issues with generic drugs. We also discuss the ongoing issues of scientific misconduct that are springing up left and right in academia, and how universities are scrambling to keep up.
Fierce Healthcare
FEBRUARY 12, 2024
An “overwhelming” 88% of respondents reporting healthcare discrimination in a new screening initiative were Black, according to a new Humana study. | An “overwhelming” 88% of respondents reporting healthcare discrimination in a new screening initiative were Black, according to a new Humana study.
pharmaphorum
FEBRUARY 12, 2024
Changing Faces: Agency, consultancy, and investor hires from January 2024 highlights the recent hires and movements in prominent companies such as Permira, Cuttsy+Cuttsy, SV Health Investors, and Cure Ventures. Stay updated with the latest talent appointments in the industry.
Drug Topics
FEBRUARY 12, 2024
A new study found that 52% of participants with treatment-refractory unipolar or bipolar depression achieved remission after 3 ketamine infusions.
pharmaphorum
FEBRUARY 12, 2024
Biotech giant CSL has seen almost 5% wiped off the value of its shares after one of its most anticipated pipeline products failed a phase 3 trial in heart attack patients
Drug Store News
FEBRUARY 12, 2024
Sir Anthony Hopkins, Chris Pratt, Jenna Ortega and Ice Spice are a few of the famous faces starring in campaigns for Doritos Dinamita, Pringles, Oreo and M&M’s, among others.
Drug Topics
FEBRUARY 12, 2024
The NDA submitted by Lykos Therapeutics was assigned a Prescription Drug User Fee Act date of August 11, 2024.
The Checkup by Singlecare
FEBRUARY 12, 2024
Depression is not just “feeling down.” It is a serious mental health condition known for its hallmark symptoms, such as loss of interest in formerly enjoyable activities, feelings of hopelessness or worthlessness, and tiredness or lack of energy. When you’re depressed, fatigue affects your ability to function in the daytime and impacts your sleep schedule, diet, and exercise habits.
STAT
FEBRUARY 12, 2024
While staffing crises at hospitals continue to make headlines, dental care — too often overlooked and treated as separate from medical — is also experiencing a significant workforce challenge. In my role leading dental at Sun Life U.S., which includes DentaQuest, the nation’s largest Medicaid dental benefits organization, I know full well that you cannot be healthy without a healthy mouth.
Fierce Pharma
FEBRUARY 12, 2024
When it comes to what not to do during an FDA inspection of your drug ingredient manufacturing facility, having the plant’s quality control chief intentionally give investigators the runaround by f | When it comes to what not to do during an FDA inspection of your drug ingredient manufacturing facility, having the plant’s quality control chief intentionally give investigators the runaround by fibbing about the existence of testing logs ranks high on the list.
pharmaphorum
FEBRUARY 12, 2024
Study finds that monitoring of rheumatoid arthritis patients with an Apple Watch and iPhone and AI algorithm improves on standard practices.
Expert insights. Personalized for you.
145 
Let's personalize your content